Corporate News 08-Dec-23
Marksans Pharma receives upgrade in credit ratings
Marksans Pharma has received upgrade in credit ratings for bank facilities from India Ratings and Research as under:
Fund based limits (Rs 100 crore) - IND A+/ Positive
Non fund based limits (Rs 77 crore) - IND A1+
Previous News
Marksans Pharma consolidated net profit rises 31.27% in the December 2023 quarter
( Results - Announcements 13-Feb-24 16:31 )
Marksans Pharma jumps after Q3 PAT climbs 34% YoY to Rs 83 cr
( Hot Pursuit - 13-Feb-24 15:41 )
Board of Marksans Pharma appoints director
( Corporate News - 30-May-23 17:36 )
Marksans Pharma to convene board meeting
( Corporate News - 04-Aug-23 14:03 )
Marksans Pharma consolidated net profit rises 86.01% in the March 2021 quarter
( Results - Announcements 31-May-21 14:16 )
Morepen Laboratories Ltd leads gainers in 'A' group
( Hot Pursuit - 30-Jun-22 12:00 )
Board of Marksans Pharma allots convertible warrants
( Corporate News - 23-Jul-21 14:32 )
Marksans Pharma to conduct board meeting
( Corporate News - 02-Feb-22 10:54 )
Board of Marksans Pharma recommends final dividend
( Corporate News - 31-May-21 15:37 )
Marksans Pharma to table results
( Corporate News - 28-Oct-20 14:42 )
Marksans Pharma fixes record date for dividend
( Market Beat - Reports 30-May-23 17:34 )
Other Stories
Optiemus showcases its high endurance Vajra 65 and Vajra 100 quadcopter drones
07-Oct-24 20:12
Bharat Electronics wins new orders of Rs 500 cr
07-Oct-24 20:09
Jaguar Land Rover records 3% drop in Q2 retail sales
07-Oct-24 19:42
Piccadily Agro launches limited edition Indri's 'City Series' for Bengaluru Duty Free
07-Oct-24 19:39
MOIL records best September production & sales
07-Oct-24 19:37
Electrosteel Castings acquires Singardo International
07-Oct-24 19:30
Avenue Supermarts to acquire 26% stake in FP Ampere Energy
07-Oct-24 19:28
Force Motors acquires 12.21% stake in TP Surya (SPV for solar power projects)
07-Oct-24 19:09
CreditAccess Grameen allots 3,614 equity shares under ESOP
07-Oct-24 19:07
Havells India allots 22,662 equity shares under ESPS
07-Oct-24 19:04
Back
Top
